Academic Journal
Phase (Ph) 3 Study of Patritumab (P) Plus Erlotinib (E) in Egfr Wild-Type Subjects with Advanced Non–Small Cell Lung Cancer (Nsclc)
العنوان: | Phase (Ph) 3 Study of Patritumab (P) Plus Erlotinib (E) in Egfr Wild-Type Subjects with Advanced Non–Small Cell Lung Cancer (Nsclc) |
---|---|
المؤلفون: | Paz-Ares, L., von Pawel, J., Moritz, B., Mendell, J., Jin, X., Copigneaux, C., Beckman, R. |
المصدر: | Annals of Oncology ; volume 25, page iv470 ; ISSN 0923-7534 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2014 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1093/annonc/mdu349.115 |
الاتاحة: | http://dx.doi.org/10.1093/annonc/mdu349.115 https://api.elsevier.com/content/article/PII:S0923753419526539?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753419526539?httpAccept=text/plain http://academic.oup.com/annonc/article-pdf/25/suppl_4/iv470/9691563/mdu349.115.pdf |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
رقم الانضمام: | edsbas.BFEDD477 |
قاعدة البيانات: | BASE |
كن أول من يترك تعليقا!